{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:38:59Z","timestamp":1793147939248,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001671","name":"European Synchrotron Radiation Facility","doi-asserted-by":"publisher","award":["MX\/2537"],"award-info":[{"award-number":["MX\/2537"]}],"id":[{"id":"10.13039\/501100001671","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejmech.2025.118107","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T23:22:16Z","timestamp":1756855336000},"page":"118107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Dual inhibition of carbonic anhydrase IX and glutathione peroxidase 4 as a novel strategy for ferroptosis-induced tumor cell death"],"prefix":"10.1016","volume":"300","author":[{"given":"Gioele","family":"Renzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7238-2912","authenticated-orcid":false,"given":"Paul C.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Awrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Bokhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaihui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ferraroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoukat","family":"Dedhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1470-7192","authenticated-orcid":false,"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118107_bib1","unstructured":"Global Cancer Facts & Figures, fifth ed. Atlanta: American Cancer Society, Inc. 2024."},{"key":"10.1016\/j.ejmech.2025.118107_bib2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ccell.2014.10.006","article-title":"Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia","volume":"26","author":"Jain","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2025.118107_bib3","doi-asserted-by":"crossref","first-page":"16825","DOI":"10.1074\/jbc.R117.799973","article-title":"Oxygen availability and metabolic reprogramming in cancer","volume":"292","author":"Xie","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118107_bib4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrc3579","article-title":"Disrupting proton dynamics and energy metabolism for cancer therapy","volume":"13","author":"Parks","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2025.118107_bib5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1021\/acs.chemrev.4c00278","article-title":"Multiple binding modes of inhibitors to human carbonic anhydrases: an update on the design of isoform-specific modulators of activity","volume":"125","author":"D'Ambrosio","year":"2025","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.118107_bib6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118107_bib7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118107_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.gene.2017.04.027","article-title":"Carbonic anhydrase XII functions in health and disease","volume":"623","author":"Waheed","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.ejmech.2025.118107_bib9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18632\/oncotarget.422","article-title":"Recent developments in targeting carbonic anhydrase IX for cancer therapeutics","volume":"3","author":"McDonald","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2025.118107_bib10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1158\/0008-5472.CAN-08-2470","article-title":"Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH","volume":"69","author":"Chiche","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118107_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","article-title":"The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond","volume":"38","author":"Pastorekova","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ejmech.2025.118107_bib12","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1158\/2326-6066.CIR-18-0657","article-title":"Targeting hypoxia-induced carbonic anhydrase IX enhances immune-checkpoint blockade locally and systemically","volume":"7","author":"Chafe","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ejmech.2025.118107_bib13","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1158\/0008-5472.CAN-14-3000","article-title":"Carbonic anhydrase IX promotes myeloid-derived suppressor cell mobilization and establishment of a metastatic niche by stimulating G-CSF production","volume":"75","author":"Chafe","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118107_bib14","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors","volume":"71","author":"Lou","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118107_bib15","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1200\/JCO.2001.19.16.3660","article-title":"Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma","volume":"19","author":"Chia","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118107_bib16","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/sj.bjc.6605690","article-title":"High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer","volume":"102","author":"Ilie","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2025.118107_bib17","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1158\/1078-0432.CCR-11-1877","article-title":"Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy","volume":"18","author":"McIntyre","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118107_bib18","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.gastro.2019.05.004","article-title":"Regulation of pH by carbonic anhydrase 9 mediates survival of pancreatic cancer cells with activated KRAS in response to hypoxia","volume":"157","author":"McDonald","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejmech.2025.118107_bib19","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/med.21497","article-title":"Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: three for the price of one","volume":"38","author":"Supuran","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118107_bib20","article-title":"Carbonic anhydrase IX: an atypical target for innovative therapies in cancer","volume":"1879","author":"Ronca","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.ejmech.2025.118107_bib21","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1038\/onc.2012.550","article-title":"Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche","volume":"32","author":"Lock","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2025.118107_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92928","article-title":"Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo","volume":"2","author":"Boyd","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejmech.2025.118107_bib23","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41568-018-0030-7","article-title":"Eco-evolutionary causes and consequences of temporal changes in intratumoural blood flow","volume":"18","author":"Gillies","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2025.118107_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1327310","article-title":"Co-vulnerabilities of inhibiting carbonic anhydrase IX in ferroptosis-mediated tumor cell death","volume":"10","author":"McDonald","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejmech.2025.118107_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj0364","article-title":"Genome-wide synthetic lethal screen unveils novel CAIX-NFS1\/xCT axis as a targetable vulnerability in hypoxic solid tumors","volume":"7","author":"Chafe","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2025.118107_bib26","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1158\/1535-7163.MCT-23-0041","article-title":"A carbonic anhydrase IX\/SLC1A5 Axis regulates glutamine metabolism dependent ferroptosis in hypoxic tumor cells","volume":"22","author":"Venkateswaran","year":"2023","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2025.118107_bib27","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell."},{"key":"10.1016\/j.ejmech.2025.118107_bib28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/COC.0000000000000691","article-title":"A phase 1 study of SLC-0111, a novel inhibitor of carbonic anhydrase IX, in patients with advanced solid tumors","volume":"43","author":"McDonald","year":"2020","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118107_bib29","unstructured":"clinicaltrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT03450018 (accessed January 2, 2025)."},{"key":"10.1016\/j.ejmech.2025.118107_bib30","doi-asserted-by":"crossref","first-page":"9550","DOI":"10.1038\/s41467-024-53837-7","article-title":"Inhibition of GPX4 enhances CDK4\/6 inhibitor and endocrine therapy activity in breast cancer","volume":"15","author":"Herrera-Abreu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118107_bib31","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.118107_bib32","doi-asserted-by":"crossref","first-page":"10374","DOI":"10.1021\/acs.jmedchem.4c00838","article-title":"Systematic investigation of dual-target-directed ligands","volume":"67","author":"Lembo","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118107_bib33","doi-asserted-by":"crossref","first-page":"6902","DOI":"10.1039\/D0GC02722G","article-title":"Isocyanide 2.0","volume":"22","author":"Patil","year":"2020","journal-title":"Green Chem."},{"key":"10.1016\/j.ejmech.2025.118107_bib34","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118107_bib35","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1016\/j.bmc.2007.11.033","article-title":"Selective COX-2 inhibitors. Part 2: synthesis and biological evaluation of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamides","volume":"16","author":"Lin","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118107_bib36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41589-020-0501-5","article-title":"Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles","volume":"16","author":"Eaton","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118107_bib37","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1021\/acs.jmedchem.3c01608","article-title":"Novel covalent probe selectively targeting glutathione peroxidase 4 in vivo: potential applications in pancreatic cancer therapy","volume":"67","author":"Tang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118107_bib38","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1021\/acs.jmedchem.2c01911","article-title":"First-in-Class dual hybrid carbonic anhydrase inhibitors and transient receptor potential vanilloid 1 agonists revert oxaliplatin-induced neuropathy","volume":"66","author":"Angeli","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118107_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/asia.202400067","article-title":"The dopamine D2 receptors antagonist Veralipride inhibits carbonic anhydrases: solution and crystallographic insights on human isoforms","volume":"19","author":"Angeli","year":"2024","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.ejmech.2025.118107_bib40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1021\/bi901995n","article-title":"Neutron structure of human carbonic anhydrase II: implications for proton transfer","volume":"49","author":"Fisher","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.118107_bib41","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/ije\/17.4.955","article-title":"A strengthening programme for weak associations","volume":"17","author":"Rothman","year":"1988","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.ejmech.2025.118107_bib42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118107_bib43","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41419-019-1897-2","article-title":"Metadherin enhances vulnerability of cancer cells to ferroptosis","volume":"10","author":"Bi","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2025.118107_bib44","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1039\/D4CC02118E","article-title":"Simple electrochemical synthesis of cyclic hydroxamic acids by reduction of nitroarenes","volume":"60","author":"Winter","year":"2024","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2025.118107_bib45","series-title":"HETEROCYCLIC COMPOUNDS","author":"Vendeville","year":"2020"},{"key":"10.1016\/j.ejmech.2025.118107_bib46","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.chempr.2024.02.021","article-title":"A general atomically dispersed copper catalyst for C\u2013O, C\u2013N, and C\u2013C bond formation by carbene insertion reactions","volume":"10","author":"Wang","year":"2024","journal-title":"Chem"},{"key":"10.1016\/j.ejmech.2025.118107_bib47","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1021\/acs.orglett.3c02283","article-title":"Csp3-H imination using arylazo sulfone as a N source: an approach to access imines","volume":"25","author":"Zhao","year":"2023","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.118107_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115783","article-title":"Discovery of a novel series of potent carbonic anhydrase inhibitors with selective affinity for \u03bc Opioid receptor for Safer and long-lasting analgesia","volume":"260","author":"Angeli","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118107_bib49","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1021\/acs.jmedchem.3c02254","article-title":"Novel carbonic anhydrase inhibitors with dual-tail core sulfonamide show potent and lasting effects for glaucoma therapy","volume":"67","author":"Angeli","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118107_bib50","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1021\/acsmedchemlett.4c00443","article-title":"Exploring the polypharmacological potential of PCI-27483: a selective inhibitor of carbonic anhydrases IX and XII","volume":"15","author":"D'Agostino","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118107_bib51","series-title":"Evolving Methods for Macromolecular Crystallography","first-page":"41","article-title":"Procesing diffraction data with mosflm","author":"Leslie","year":"2007"},{"key":"10.1016\/j.ejmech.2025.118107_bib52","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1107\/S0907444996012255","article-title":"Refinement of macromolecular structures by the maximum-likelihood method","volume":"53","author":"Murshudov","year":"1997","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.ejmech.2025.118107_bib53","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.ejmech.2025.118107_bib54","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/prot.10286","article-title":"Structure validation by C\u03b1 geometry: \u03d5,\u03c8 and C\u03b2 deviation","volume":"50","author":"Lovell","year":"2003","journal-title":"Proteins"},{"key":"10.1016\/j.ejmech.2025.118107_bib55","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:16:45Z","timestamp":1760023005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425008724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":55,"alternative-id":["S0223523425008724"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118107","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual inhibition of carbonic anhydrase IX and glutathione peroxidase 4 as a novel strategy for ferroptosis-induced tumor cell death","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118107"}}